Man Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.42M Buy
210,624
+171,302
+436% +$3.97M 0.01% 1095
2026
Q1
$809K Buy
+39,322
New +$886K ﹤0.01% 1907
2023
Q3
Sell
-94,640
Closed -$2.47M 2102
2023
Q2
$2.47M Buy
+94,640
New +$2.5M 0.01% 1123
2023
Q1
Hold
0
1247
2022
Q4
Sell
-41,367
Closed -$1.41M 2164
2022
Q3
$1.41M Buy
+41,367
New +$1.53M 0.01% 1180
2022
Q2
Sell
-27,337
Closed -$695K 1835
2022
Q1
$730K Buy
+27,337
New +$645K ﹤0.01% 1470

Other funds holding PRVA

Man Group's PRVA Position: Q2 2026 in Review

Man Group increased its Privia Health (PRVA) stake by 436% in Q2 2026, buying an estimated $3.97M and bringing the position to 210,624 shares worth $5.42M. The position accounts for 0.01% of the portfolio, ranked #1095.

Man Group first reported a position in PRVA in Q1 2022 and has held it in 5 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Man Group held 210,624 shares of Privia Health worth $5.42M as of Q2 2026.
  • Man Group bought 171,302 Privia Health shares in Q2 2026, an estimated $3.97M.
  • Privia Health made up 0.01% of Man Group's portfolio in Q2 2026, its #1095 holding.
  • Man Group first reported a position in Privia Health in Q1 2022 and has held it in 5 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.